Bitcoin Magazine Bitcoin Price Falls to $72,000 as Fed Uncertainty Triggers Pullback Bitcoin price dropped to the low $72,000's early Wednesday, retreating fromBitcoin Magazine Bitcoin Price Falls to $72,000 as Fed Uncertainty Triggers Pullback Bitcoin price dropped to the low $72,000's early Wednesday, retreating from

Bitcoin Price Falls to $72,000 as Fed Uncertainty Triggers Pullback

2026/03/18 21:03
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Bitcoin Magazine

Bitcoin Price Falls to $72,000 as Fed Uncertainty Triggers Pullback

Bitcoin price dropped to the low $72,000 range early Wednesday, retreating from recent highs as traders reduced risk ahead of the Federal Reserve’s latest decision.

The pullback follows a strong multi-day rally that pushed the asset close to $75,000, its highest level since early February. That move has now stalled. Profit-taking has increased, and market participants appear reluctant to open new positions without clarity on macro conditions.

Trading activity reflects the shift in sentiment. Daily volume has declined sharply, signaling weaker conviction behind recent price action. 

In derivatives markets, futures open interest has flattened while funding rates have turned mixed to slightly negative, pointing to a more defensive positioning. 

Traders who were forced out of short positions during the rally have largely stayed on the sidelines, waiting for a clearer trend.

The Federal Reserve meeting later on Wednesday remains the central focus.

The Federal Reserve is expected to hold interest rates steady as it assesses how rising oil prices tied to the Iran conflict could impact inflation and economic growth. Markets now anticipate rate cuts later in the year, while Chair Jerome Powell is likely to signal a cautious, wait-and-see approach alongside new economic projections.

Markets are pricing in a near-certain pause in interest rates, but uncertainty around inflation and economic growth continues to weigh on risk assets. 

Oil prices near $100 per barrel, driven by ongoing conflict in the Middle East, are adding upward pressure on inflation. At the same time, softer U.S. labor data complicates the outlook, reducing the likelihood of aggressive rate cuts in the near term.

Bitcoin price’s recent behavior around Fed meetings adds to the caution. Historical data shows the asset has often declined in the immediate aftermath of policy announcements, regardless of the outcome. 

Bitcoin price resilence

Despite the short-term weakness, Bitcoin price has shown resilience on a broader timeframe. Since late February, the asset has gained while traditional markets like equities and gold have struggled. 

Analysts attribute this divergence to continued inflows into spot Bitcoin exchange-traded funds and sustained accumulation from institutional players, which have helped reshape the asset’s ownership structure.

However, signs of potential selling pressure are emerging. On-chain data shows a rise in Bitcoin moving onto exchanges, often a precursor to distribution. 

At the same time, analysts highlight the $75,000 to $85,000 range as a significant resistance zone, where previous rallies have stalled.

For now, Bitcoin price appears to be consolidating as markets wait for direction. The outcome of the Fed meeting, and more importantly, the tone of its guidance, is likely to determine whether the current pullback deepens or sets the stage for another attempt higher.

bitcoin price

This post Bitcoin Price Falls to $72,000 as Fed Uncertainty Triggers Pullback first appeared on Bitcoin Magazine and is written by Micah Zimmerman.

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1.381
$1.381$1.381
-0.34%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26